OncoVista Innovative Therapies, Inc. (OVIT)
Develops cancer drugs that target specific tumor markers.
$0.00+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+0.0%
The outlook
OVIT is trading at its 52-week low with a bearish overall score of 22/100. The price shows mixed positioning relative to its moving averages, suggesting no clear directional momentum. Analyst coverage appears limited or unavailable for this micro-cap stock.
What’s behind the score
Price trendMixed vs its moving averages
52-week range0% of the way from its 52-week low to high
Market cap
$2,355
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—